THOMASVILLE — Novant Health Cancer Institute in Thomasville has completed a major expansion. The work added exam rooms, ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national ...
News Nation on MSN
Why ‘Dry January’ can go a long way toward cancer prevention
It doesn’t matter how much you drink — the risk to the drinker’s health starts from the first drop of any alcoholic beverage, ...
5d
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at ...
Lucid Capital Markets is acting as the sole book-running manager for the proposed offering.
Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced the closing of its previously ...
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...
Successful implementation requires modern healthcare infrastructure, including reliable electricity, high-speed internet ...
THOMASVILLE — Novant Health Cancer Institute in Thomasville has completed a major expansion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback